Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPARα Signaling Pathway

Table 4

Differential gene KEGG pathway between LZG group and model group (PPI database).

Pathway	Description	Count in network	Strength	False discovery rate
mmu01040	Biosynthesis of unsaturated fatty acids	4 of 27	2.4	9.94e − 08
mmu00062	Fatty acid elongation	3 of 26	2.29	1.27e − 05
mmu00410	Beta-alanine metabolism	2 of 32	2.03	0.0011
mmu01212	Fatty acid metabolism	3 of 51	2.0	4.53e − 05
mmu00380	Tryptophan metabolism	2 of 45	1.88	0.0019
mmu04976	Bile secretion	3 of 71	1.86	8.90e − 05
mmu00071	Fatty acid degradation	2 of 50	1.83	0.0020
mmu00280	Valine, leucine, and isoleucine degradation	2 of 55	1.79	0.0022
mmu03320	PPAR signaling pathway	3 of 85	1.78	0.00012
mmu04913	Ovarian steroidogenesis	2 of 57	1.77	0.0022
mmu01212	Lysine degradation	2 of 58	1.77	0.0022
mmu01212	Glycerolipid metabolism	2 of 60	1.75	0.0022
mmu01212	Steroid hormone biosynthesis	2 of 83	1.61	0.0035
mmu01212	Metabolic pathways	7 of 1296	0.96	4.53e − 05